The US Food and Drug Administration (FDA) has approved the Abbott FreeStyle Libre 2 iOS application for checking glucose levels to manage diabetes.
The accessible and cost-effective sensor-based glucose monitoring app permits customers to read their glucose levels on compatible iPhones without requiring a reader.
It facilitates a complete digital offering for Abbott’s FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system.